Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacotherapies and Personalized Medicine for Alcohol Use Disorder: A Review
Falk W. Lohoff
Pharmacogenomics (2020) Vol. 21, Iss. 15, pp. 1117-1138
Open Access | Times Cited: 25

Showing 25 citing articles:

Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder
Sophie Köhne, Thomas Hillemacher, Alexander Glahn, et al.
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 3, pp. 219-232
Closed Access | Times Cited: 5
Disulfiram alleviates immune-mediated liver injury by inhibiting pyroptosis in hepatocytes through the NF-κB pathway
Wanyuan Xiong, Junfeng Li, Xiaorong Mao, et al.
European Journal of Pharmacology (2025) Vol. 992, pp. 177352-177352
Closed Access
Genetic liability for anxiety and treatment response to the monoamine stabilizer OSU6162 in alcohol dependence: a retrospective secondary analysis
Mun‐Gwan Hong, Lotfi Khemiri, Joar Guterstam, et al.
Pharmacological Reports (2025)
Open Access
Pharmacogenomic and Pharmacomicrobiomic Aspects of Drugs of Abuse
Alejandro Borrego-Ruiz, Juan J. Borrego
Genes (2025) Vol. 16, Iss. 4, pp. 403-403
Open Access
Role of Nanomedicine in Transforming Pharmacotherapy for Substance Use Disorder (SUD)
Akshata Y. Patne, Subhra Mohapatra, Shyam S. Mohapatra
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2025) Vol. 17, Iss. 2
Open Access
Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol use disorder endophenotypes
Bankole A. Johnson, Hannu Alho, Giovanni Addolorato, et al.
European Journal of Internal Medicine (2024) Vol. 127, pp. 50-62
Open Access | Times Cited: 4
PCSK9 and the Gut-Liver-Brain Axis: A Novel Therapeutic Target for Immune Regulation in Alcohol Use Disorder
Ji Soo Lee, Emma M. O’Connell, Pál Pacher, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1758-1758
Open Access | Times Cited: 26
Targeting Unmet Clinical Needs in the Treatment of Alcohol Use Disorder
Falk W. Lohoff
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 18
The role of resilience in the relationship between stress and alcohol
Melanie L. Schwandt, Eva Cullins, Vijay A. Ramchandani
Neurobiology of Stress (2024) Vol. 31, pp. 100644-100644
Open Access | Times Cited: 3
Alcohol use disorder is associated with DNA methylation-based shortening of telomere length and regulated by TESPA1: implications for aging
Jeesun Jung, Daniel L. McCartney, Josephin Wagner, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 9, pp. 3875-3884
Open Access | Times Cited: 15
Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology
Lindsay R. Meredith, Elizabeth M. Burnette, Steven J. Nieto, et al.
Alcohol Clinical and Experimental Research (2023) Vol. 47, Iss. 9, pp. 1629-1645
Closed Access | Times Cited: 7
Substance Use Disorders: Confronting Addiction From Prevention to Recovery
Kathleen T. Brady, Ned H. Kalin
American Journal of Psychiatry (2024) Vol. 181, Iss. 5, pp. 347-348
Closed Access | Times Cited: 2
The genetic landscape of substance use disorders
Zachary F. Gerring, Jackson G. Thorp, Jorien L. Treur, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 11, pp. 3694-3705
Open Access | Times Cited: 2
EFFICACY OF MEDICATIONS FOR THE TREATMENT OF ALCOHOL USE DISORDER (AUD): A SYSTEMATIC REVIEW AND META-ANALYSIS CONSIDERING BASELINE AUD SEVERITY
Roberta Agabio, Hugo López‐Pelayo, Pol Bruguera, et al.
Pharmacological Research (2024) Vol. 209, pp. 107454-107454
Open Access | Times Cited: 2
A causal relationship between alcohol intake and type 2 diabetes mellitus: A two-sample Mendelian randomization study
Meiling Liu, Sunmin Park
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 32, Iss. 12, pp. 2865-2876
Closed Access | Times Cited: 12
Cholesterol and alcohol
Andrew S. Bell, Emma M. O’Connell, Falk W. Lohoff
Elsevier eBooks (2022), pp. 747-767
Closed Access | Times Cited: 6
Multi‐omics analysis of alcohol effects on the liver in young and aged mice
Lea Zillich, Josephin Wagner, Rachel H. McMahan, et al.
Addiction Biology (2023) Vol. 28, Iss. 12
Open Access | Times Cited: 3
Burden of alcohol use disorders in China and the regions with different income levels over the world
Xiang Qu, Mi Liu, Changrong Ke, et al.
Journal of Global Health (2021) Vol. 11
Open Access | Times Cited: 8
The Genetics of Alcohol Use Disorder
Josephin Wagner, Andrew S. Bell, Jeesun Jung, et al.
Springer eBooks (2023), pp. 595-621
Closed Access | Times Cited: 2
Genetic liability for anxiety associates with treatment response to the monoamine stabilizer OSU6162 in alcohol dependence
Mun‐Gwan Hong, Lotfi Khemiri, Joar Guterstam, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Advances in research on medications for the treatment of alcohol use disorders: A review
Y Chen, Luxin Zong, Qiran Zhao, et al.
Medicine (2024) Vol. 103, Iss. 42, pp. e40045-e40045
Open Access
“I Think I Hit My Head”

Cambridge University Press eBooks (2024), pp. 5-9
Closed Access
Approved, Promising, and Experimental Medications for Treatment of Alcohol Use Disorder
András H. Lékó, Mehdi Farokhnia, Lorenzo Leggio
Springer eBooks (2023), pp. 261-288
Closed Access
A Phase 3 Randomized Precision Medicine Clinical Trial Using Low-Dose Ondansetron (a 5-HT3 Antagonist) to Treat Alcohol Use Disorder
Bankole A. Johnson, Hannu Alho, Giovanni Addolorato, et al.
Research Square (Research Square) (2023)
Open Access
PERFIL FARMACOLÓGICO PARA DESINTOXICAÇÃO DA DEPENDÊNCIA QUÍMICA – REVISÃO SISTEMÁTICA
Rosana Lima de Oliveira, Lenise Socorro Benarrós de Mesquita
Brazilian Journal of Implantology and Health Sciences (2023) Vol. 5, Iss. 5, pp. 6036-6057
Open Access
Page 1

Scroll to top